In January 2025, you said that the new diabetes and weight-loss medications called GLP-1 drugs appeared to reduce the risk of many major diseases, by reducing inflammation
Compared to retatrutides results, previous trials for Ozempic showed a 15% weight reduction over 68 weeks, while Mounjaro helped users shed up to 22.5% of their body weight over 72 weeks
By late 2025, that group had nearly doubled
Di Petrillo A, Kumar A, Onali S, Favale A, Fantini MC
Shotsy's estimated medication level charts show the amount of each medication in your system simultaneously, so you can see how different drugs overlap and interact
Additional peptide binds non-specifically to serum albumin rather than target receptors